PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs
PhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.
The company aims to move cancer treatment programs into preclinical development with this new funding.
Generative AI will be designing new drugs all on its own in the near future
AI-driven molecule design can lead to novel drug candidates outside human imagination, pushing boundaries in medicine development.
Generative AI: Powering the next era of life sciences innovations
Generative AI in life sciences landscape is poised to drive innovation, offering solutions for drug discovery, clinical trials, and manufacturing processes.
PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs
PhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.
The company aims to move cancer treatment programs into preclinical development with this new funding.
Generative AI will be designing new drugs all on its own in the near future
AI-driven molecule design can lead to novel drug candidates outside human imagination, pushing boundaries in medicine development.
Generative AI: Powering the next era of life sciences innovations
Generative AI in life sciences landscape is poised to drive innovation, offering solutions for drug discovery, clinical trials, and manufacturing processes.
Cambridge startup analyses 'multi-omics' data to discover new heart drugs
CardiaTec raises $6.5mn to enhance drug discovery for cardiovascular diseases using AI-driven multi-omics data analysis.
Bloomberg
1. AI is playing a crucial role in the fight against the COVID-19 pandemic, helping to analyze large amounts of data and develop solutions.
2. DeepMind's AlphaFold has shown promising results in predicting protein structures, a key step in understanding diseases and developing targeted therapies.
Bloomberg
Companies are using artificial intelligence (AI) to find new drugs and treatments for diseases.
Google's DeepMind is partnering with EMBL in Germany to use AI to identify proteins that cause diseases.
Cambridge startup analyses 'multi-omics' data to discover new heart drugs
CardiaTec raises $6.5mn to enhance drug discovery for cardiovascular diseases using AI-driven multi-omics data analysis.
Bloomberg
1. AI is playing a crucial role in the fight against the COVID-19 pandemic, helping to analyze large amounts of data and develop solutions.
2. DeepMind's AlphaFold has shown promising results in predicting protein structures, a key step in understanding diseases and developing targeted therapies.
Bloomberg
Companies are using artificial intelligence (AI) to find new drugs and treatments for diseases.
Google's DeepMind is partnering with EMBL in Germany to use AI to identify proteins that cause diseases.
The enigma of the rare genetic mutation that protects against cancer and heart attacks
Genetic mutation in Ecuadorian families with Laron Syndrome protects from cardiovascular diseases, potential for drug discovery for aging-related diseases.
AI Is Transforming Drug Matching for Cancer, Rare Diseases | Entrepreneur
AI tools are revolutionizing drug discovery for rare diseases by repurposing existing medications, leading to cost-effective and efficient screening processes.
Refining the impact of genetic evidence on clinical success - Nature
Human genetics is crucial in identifying potential drug targets but faces challenges in application to drug discovery.
ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries
ADMET-AI is a machine learning platform predicting drug properties like absorption, distribution, metabolism, excretion, and toxicity.
Chemprop-RDKit uses a hybrid architecture to predict molecular properties, combining graph neural networks with feed-forward neural network layers.
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project
Novo Nordisk is investing in an AI supercomputer through collaboration with Nvidia for drug discovery and other scientific advancements.
The Novo Nordisk Foundation's investment in the AI supercomputer is aimed at accelerating groundbreaking scientific discoveries and fostering collaboration between academia and industry.
EvolutionaryScale, backed by Amazon and Nvidia, raises $142M for protein-generating AI | TechCrunch
EvolutionaryScale raised $142 million to build AI models for creating novel proteins in scientific research.
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project
Novo Nordisk is investing in an AI supercomputer through collaboration with Nvidia for drug discovery and other scientific advancements.
The Novo Nordisk Foundation's investment in the AI supercomputer is aimed at accelerating groundbreaking scientific discoveries and fostering collaboration between academia and industry.
EvolutionaryScale, backed by Amazon and Nvidia, raises $142M for protein-generating AI | TechCrunch
EvolutionaryScale raised $142 million to build AI models for creating novel proteins in scientific research.
These Companies are Changing Biotech & Biopharma with AI in 2024
AI is revolutionizing the BioTech & BioPharma space by accelerating drug discovery and development processes.
Companies like Insilico Medicine and Exscientia are using AI platforms to design and optimize drug candidates, leading to faster timelines and more efficient drug development.
Karim Beguir Wants to Empower the World With AI
InstaDeep, a decision-making AI company, has challenged the tech status quo by setting up shop in Tunis and operating in the complex domain of deep tech.
The company builds AI systems that can make decisions for businesses, with applications ranging from drug discovery to energy efficiency.
Podcast: AI-Enabled Drug Discovery with Daphne Koller
Daphne Koller discusses AI's role in biotechnology, specifically drug discovery.
The importance of high-quality data and ethical considerations in using AI for biotechnology.
Bloomberg
Google's AI research lab, DeepMind, has developed a new algorithm for generating computer programs.
The algorithm, called AlphaFold, uses deep learning to predict the 3D structure of proteins.
AI Program Finds Thousands of Possible Psychedelics. Will They Lead to New Drugs?
AlphaFold, an AI tool developed by DeepMind, has been used to identify new potential psychedelic molecules for developing antidepressants.
AlphaFold predictions can be just as useful for drug discovery as experimentally derived protein structures.
'Supermodel granny' drug extends life in animals
A drug increased lab animals' lifespan by 25% with potential for human aging; impact on inflammation control identified.
Sick chimpanzees self-medicate using plants with medicinal properties
Chimpanzees in Uganda self-medicate with medicinal plants rich in antibacterial and anti-inflammatory properties, suggesting a potential for discovering new drugs through studying their behavior.